美国 · SEC FORM 4
ELI LILLY & Co
LLY · NYSE · CIK 0000059478 · Healthcare · Drug Manufacturers—General
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
31 同一窗口内观察到的 Form 4 交易行
6 sales · 25 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 6 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-08-15 · Montarce Lucas.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 7,035,434
- 上期报告
- 7,519,918
- 日均成交量
- 2,400,203
- 回补天数
- 2.9
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-08-15 | Montarce Lucas | 买入 (P) | Common Stock | 715 | USD 691.79 | USD 494,630 | SEC 申报 ↗ |
| 2025-08-13 | Alvarez Ralph | 买入 (P) | Common Stock | 758 | USD 660.25 | USD 500,470 | SEC 申报 ↗ |
| 2025-08-13 | Van Naarden Jacob | 买入 (P) | Common Stock | 1,000 | USD 647.36 | USD 647,360 | SEC 申报 ↗ |
| 2025-08-12 | Sulzberger Gabrielle | 买入 (P) | Common Stock | 117 | USD 641.18 | USD 75,018 | SEC 申报 ↗ |
| 2025-08-12 | Skovronsky Daniel | 买入 (P) | Common Stock | 1,000 | USD 634.41 | USD 634,410 | SEC 申报 ↗ |
| 2025-08-12 | Ricks David A | 买入 (P) | Common Stock | 1,632 | USD 644.77 | USD 1,052,265 | SEC 申报 ↗ |
| 2025-08-12 | Fyrwald J Erik | 买入 (P) | Common Stock | 1,565 | USD 642.33 | USD 1,005,249 | SEC 申报 ↗ |
| 2025-08-08 | JACKSON JAMERE | 买入 (P) | Common Stock | 200 | USD 639.56 | USD 127,912 | SEC 申报 ↗ |
| 2022-08-12 | TAI JACKSON P | 买入 (P) | Common Stock | 656 | USD 304.19 | USD 199,549 | SEC 申报 ↗ |
| 2022-03-01 | Runge Marschall S | 买入 (P) | Common Stock | 202 | USD 246.78 | USD 49,850 | SEC 申报 ↗ |
| 2021-04-30 | TAI JACKSON P | 买入 (P) | Common Stock | 1,366 | USD 182.84 | USD 249,759 | SEC 申报 ↗ |
Form 4 申报证据
357 transaction lines in the latest 365-day window; 1,984 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-21 | Sulzberger Gabrielle | 奖励／授予 (A) | Common Stock | 4 | USD 1,164.89 | USD 4,962 | SEC 申报 ↗ |
| 2026-09-21 | LUCIANO JUAN R | 奖励／授予 (A) | Common Stock | 14 | USD 1,164.89 | USD 15,912 | SEC 申报 ↗ |
| 2026-09-21 | Fyrwald J Erik | 奖励／授予 (A) | Common Stock | 9 | USD 1,164.89 | USD 9,913 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-21 | Sulzberger Gabrielle | 奖励／授予 (A) | Common Stock | 4 | USD 1,164.89 | USD 4,962 | SEC 申报 ↗ |
| 2026-09-21 | LUCIANO JUAN R | 奖励／授予 (A) | Common Stock | 14 | USD 1,164.89 | USD 15,912 | SEC 申报 ↗ |
| 2026-09-21 | Fyrwald J Erik | 奖励／授予 (A) | Common Stock | 9 | USD 1,164.89 | USD 9,913 | SEC 申报 ↗ |
| 2026-09-21 | Alvarez Ralph | 奖励／授予 (A) | Common Stock | 11 | USD 1,164.89 | USD 12,418 | SEC 申报 ↗ |
| 2026-09-09 | Seymour Melissa | 赠与 (G) | Common Stock | 12 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-02 | Hernandez Edgardo | 赠与 (G) | Common Stock | 13 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-02 | Dozier Eric | 赠与 (G) | Common Stock | 216 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-17 | Sulzberger Gabrielle | 奖励／授予 (A) | Common Stock | 4 | USD 1,183.16 | USD 4,957 | SEC 申报 ↗ |
| 2026-08-17 | LUCIANO JUAN R | 奖励／授予 (A) | Common Stock | 13 | USD 1,183.16 | USD 15,914 | SEC 申报 ↗ |
| 2026-08-17 | Jonsson Patrik | 卖出 (S) | Common Stock | 6,500 | USD 1,175.10 | USD 7,638,150 | SEC 申报 ↗ |
| 2026-08-17 | Fyrwald J Erik | 奖励／授予 (A) | Common Stock | 8 | USD 1,183.16 | USD 9,915 | SEC 申报 ↗ |
| 2026-08-17 | Alvarez Ralph | 奖励／授予 (A) | Common Stock | 10 | USD 1,183.16 | USD 12,411 | SEC 申报 ↗ |
| 2026-08-10 | Zakrowski Donald A | 卖出 (S) | Common Stock | 2,000 | USD 1,185.01 | USD 2,370,020 | SEC 申报 ↗ |
| 2026-08-07 | Hakim Anat | 卖出 (S) | Common Stock | 5,000 | USD 1,190.00 | USD 5,950,000 | SEC 申报 ↗ |
| 2026-08-01 | Seymour Melissa | 期权行权／转换 (M) | Common Stock | 981 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-01 | Seymour Melissa | 代扣税 (F) | Common Stock | 439 | USD 1,148.84 | USD 504,008 | SEC 申报 ↗ |
| 2026-07-20 | Sulzberger Gabrielle | 奖励／授予 (A) | Common Stock | 4 | USD 1,146.90 | USD 4,955 | SEC 申报 ↗ |
| 2026-07-20 | LUCIANO JUAN R | 奖励／授予 (A) | Common Stock | 14 | USD 1,146.90 | USD 15,919 | SEC 申报 ↗ |
| 2026-07-20 | Fyrwald J Erik | 奖励／授予 (A) | Common Stock | 9 | USD 1,146.90 | USD 9,921 | SEC 申报 ↗ |
| 2026-07-20 | Alvarez Ralph | 奖励／授予 (A) | Common Stock | 11 | USD 1,146.90 | USD 12,421 | SEC 申报 ↗ |
| 2026-06-15 | Sulzberger Gabrielle | 奖励／授予 (A) | Common Stock | 4 | USD 1,129.35 | USD 4,958 | SEC 申报 ↗ |
| 2026-06-15 | LUCIANO JUAN R | 奖励／授予 (A) | Common Stock | 14 | USD 1,129.35 | USD 15,913 | SEC 申报 ↗ |
| 2026-06-15 | Fyrwald J Erik | 奖励／授予 (A) | Common Stock | 9 | USD 1,129.35 | USD 9,916 | SEC 申报 ↗ |
| 2026-06-15 | Alvarez Ralph | 奖励／授予 (A) | Common Stock | 11 | USD 1,129.35 | USD 12,412 | SEC 申报 ↗ |
| 2026-06-10 | Yuffa Ilya | 卖出 (S) | Common Stock | 2,500 | USD 1,150.77 | USD 2,876,925 | SEC 申报 ↗ |
| 2026-05-18 | Sulzberger Gabrielle | 奖励／授予 (A) | Common Stock | 5 | USD 988.09 | USD 4,960 | SEC 申报 ↗ |
| 2026-05-18 | LUCIANO JUAN R | 奖励／授予 (A) | Common Stock | 16 | USD 988.09 | USD 15,918 | SEC 申报 ↗ |
| 2026-05-18 | Fyrwald J Erik | 奖励／授予 (A) | Common Stock | 10 | USD 988.09 | USD 9,920 | SEC 申报 ↗ |
| 2026-05-18 | Alvarez Ralph | 奖励／授予 (A) | Common Stock | 13 | USD 988.09 | USD 12,420 | SEC 申报 ↗ |
| 2026-05-06 | LILLY ENDOWMENT INC | 卖出 (S) | Common Stock | 15,828 | USD 995.36 | USD 15,754,598 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | LLY |
| CIK | 0000059478 |
| 行业 | Healthcare |
| 细分行业 | Drug Manufacturers—General Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | NYSE |
数据覆盖
| 本地 Form 4 历史 | 1,984 transaction lines from 2020-01-07 to 2026-09-21 13 P purchase lines · 1,270 S sale lines · 701 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.